New WHO recommendations for MDR-TB will lower the cost of treatment and improve outcomes

13 May 2016
New regimen will generate savings for The Global Fund

The World Health Organization has issued new recommendations for the treatment of multi-drug-resistant TB, involving the use of a regimen that is shorter and cheaper compared to what is currently being used.

Subscribe to cost